Co-Founder & CEO

Chief Operating Officer

FMOL Health Shows Drastic Reduction in Sepsis Related Deaths

New Data Reveals Path to SEP-1 Success Includes Early Sepsis Risk Stratification

Study: Cytovale’s Rapid Sepsis Test Helps Increase Safe ED Discharges

Cytovale's Rapid Sepsis Test Drives 56% Increase in ED Discharges Without Compromise to Patient Safety, Study Finds

Director of Marketing - Demand Generation

Cytovale is a dynamic, early-stage commercial organization focused on developing innovative diagnostic solutions for sepsis detection. The Director of Demand Generation will lead marketing strategies to enhance awareness and generate a qualified pipeline for the IntelliSep test, collaborating with various teams to drive effective demand generation programs in the acute-care hospital sector.

Sign up with Google

Sign in with Google